Agios’s $345 Million Repurchase Agreement With Bristol-Myers Squibb Company

Wachtell, Lipton, Rosen & Katz advised Agios Pharmaceuticals on the deal.Agios Pharmaceuticals, Inc. entered into a Share Repurchase Agreement with Bristol-Myers Squibb Company, pursuant to which Agios…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now